Victory Capital Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Buy
114,839
+80,755
+237% +$1.9M ﹤0.01% 1524
2026
Q1
$510K Buy
34,084
+241
+0.7% +$4.11K ﹤0.01% 2030
2025
Q4
$493K Buy
33,843
+1,030
+3% +$18K ﹤0.01% 2023
2025
Q3
$589K Sell
32,813
-290,074
-90% -$4.25M ﹤0.01% 2009
2025
Q2
$5.51M Buy
322,887
+220,789
+216% +$2.21M ﹤0.01% 1284
2025
Q1
$739K Buy
102,098
+72,208
+242% +$822K ﹤0.01% 1925
2024
Q4
$420K Buy
29,890
+3,257
+12% +$48.1K ﹤0.01% 2070
2024
Q3
$316K Buy
26,633
+7,814
+42% +$81K ﹤0.01% 2124
2024
Q2
$175K Buy
+18,819
New +$96.1K ﹤0.01% 2228

Other funds holding CORZ

Victory Capital Management's CORZ Position: Q2 2026 in Review

Victory Capital Management increased its Core Scientific (CORZ) stake by 237% in Q2 2026, buying an estimated $1.9M and bringing the position to 114,839 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Victory Capital Management first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.51M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Victory Capital Management held 114,839 shares of Core Scientific worth $2.94M as of Q2 2026.
  • Victory Capital Management bought 80,755 Core Scientific shares in Q2 2026, an estimated $1.9M.
  • Core Scientific made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1524 holding.
  • Victory Capital Management first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • Victory Capital Management's Core Scientific position peaked at $5.51M in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.